Molecular Partners is a privately owned biopharmaceutical company, located in Zurich, Switzerland, that is pioneering the development of a novel class of targeted protein therapeutics termed DARPins. DARPins are as target specific and potent as monoclonal antibodies. Yet, being small proteins, they overcome the known limitations of conventional protein-based therapeutic approaches.
31.10.2025
More than 20 Swiss biotech companies to exhibit at Bio Europe (startupticker.ch)
10.06.2025
Molecular Partners vor Massenentlassung (startupticker.ch)
05.11.2024
Bio Europe in Stockholm hosts 33 Swiss companies (startupticker.ch)
31.05.2024
Swiss life science startups headed for San Diego (startupticker.ch)
30.05.2023
Positive results for Swiss biotechs’ clinical studies (startupticker.ch)
No Jobs
No videos and documents
The venture business plan competition takes place every year and combines a competition, learning events and contact form in one. It is an initiative of the ETH Zurich, CTI and McKinsey.
CTI Start-up enables entrepreneurs to realize their innovative idea professionally.
In a process of three phases, over forty experienced coaches guide start-up companies on their way to enter the market successfully and attract financing. At the end of the coaching process, the most promising start-up companies have the opportunity to receive the prestigious CTI Start-up ’Label’. In addition, the companies benefit from the wide CTI Start-up network of industry experts, experienced entrepreneurs, business angels, venture capitalists and has access to foundations such as de Vigier, STI, FIT, Gebert, Rüf, etc.
Until today, CTI Start-up reviewed more than 1 800 projects, and awarded over 200 start-up enterprises with the CTI Start-up Label. Over 85% of these companies are still in business and some have shown remarkable growth, which is a sign that CTI Start-up guides them to sustainable success.
CTI also promotes the culture of entrepreneurship at universities, teaching hospitals, technical institutes as well as universities of applied sciences. CTI Entrepreneurship offers workshops to students on how to bring innovation to the market.
Seit 1987 fördert die W.A. de Vigier Stiftung zukunftweisende Geschäftsideen mit einem Förderpreis von je 5 x CHF 100'000. Nebst diesem Startkapital erhalten die Preisträger auch immaterielle Unterstützung; etwa in Form von wertvollen Kontakten, Medientrainings sowie Präsenz in Presse, TV und Radio. W.A. de Vigier Stiftung versteht ihr Engagement als Beitrag zu einer wettbewerbsstarken und gesunden Schweizer Wirtschaft.
Website:
www.molecularpartners.com
Headquarter:
Zürich-Schlieren
Foundation Date:
November 2004
Technology:
Sectors: